🇺🇸 FDA
Patent

US 11998516

Methods and compositions for treating depression using cyclobenzaprine

granted A61KA61K31/137A61K45/06

Quick answer

US patent 11998516 (Methods and compositions for treating depression using cyclobenzaprine) held by TONIX PHARMA LIMITED expires Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TONIX PHARMA LIMITED
Grant date
Tue Jun 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/137, A61K45/06, A61P, A61P25/24